Celltrion USA has expanded access toZYMFENTRA®(infliximab-dyyb),the first and only FDA-approved subcutaneous (SC) infliximab,to a significant share of the U.S. market
This approval marks the second international marketing authorization forsugemalimab outside of China,following its recent approval by the European Commission.
BEIJING,Oct. 31,2024-- The main structure of a new branch of the Palace Museum located inHaidian district of Beijing is expected to meet its primary structural milestone by the end of 2024,the Beijing
Autodesk,Inc.,Biogen Inc.,EMD Electronics and Wayfair Inc. are now purchasing renewable energy from the Texas project
BOSTON,Oct. 31,2024-- In a remarkable development for cancer research,patients with advanced-stage cancer have benefited fromSUPLEXA,a personalized treatment that trains the patient\'s own immune cel
HONG KONG,Oct. 31,2024-- The Hong Kong Monetary Authority (HKMA) today introduced WeBank Technology Services,JPMorgan Chase Bank,National Association and R3 as new members of the Project Ensemble Arch
